Telix pulls $300m Nasdaq IPO as investors demand deep discount
MELBOURNE: Cancer treatment hopeful Telix Pharmaceuticals has abruptly pulled plans to raise $US200 million ($300
MELBOURNE: Cancer treatment hopeful Telix Pharmaceuticals has abruptly pulled plans to raise $US200 million ($300
FEATURED
Six-storey social housing development now on drawing board
Later-life divorces rise as many silver splitter women end up happier
Wealthy downsizers flock to hotel-style units in inner suburbs
Developer to create new multigenerational community on regeneration site
Affordable housing group open 81-unit seniors housing community
Special research team creates ‘predictive medicine’ AI tool
INNOVATION
